Press Release

Hero overlay Cancer research Analyst Coverage Annual Report Proxy Materials Corporate Governance Events Presentations Financial Information Investor Disclaimer Press Releases Stock Information
Back

PacBio to Present at Upcoming Investor Conferences

November 13, 2025 at 4:05 PM EST

MENLO PARK, Calif., Nov. 13, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences:

  • Wolfe Research Healthcare Conference 2025 in New York, NY
    Fireside chat on Tuesday, November 18 at 8:40 AM ET
  • Jefferies Global Healthcare Conference in London, UK
    Hosting 1x1 meetings only on Wednesday, November 19
  • Stephens Annual Investment Conference in Nashville, TN
    Fireside chat on Wednesday, November 19 at 10:00 AM CT

Live webcasts of the fireside chats can be accessed at the company's investors page at investor.pacificbiosciences.com. Webcast replays will be available for at least 30 days following the event.

About PacBio

PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.

PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.

Contacts

Investors:
ir@pacb.com

Media:
pr@pacb.com


Investor Contact

Pacific Biosciences of California, Inc.
1305 O’Brien Drive, Menlo Park, CA 94025
ir@pacb.com